Get started
Author

O. A. Malievskiy

Observed names: Malievskiy O, Malievsky, Oleg, O A Malievskiy, O. A. Malievsky, O. A. Мalievsky, O., Malievskiy, O.A. Malievskiy, Olag Malievsky, Oleg A Malievskiy, Oleg A. Malievskiy, Oleg A. Malievsky, Oleg A. Мalievsky, Oleg Arturovich Malievskiy, Oleg Malievskiy, Oleg Malievsky
ORCID: 0000-0003-2599-0867
Observed ORCID: 0000-0003-2599-0867
OpenAlex ID: A5089188116
Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study
2018 · Pamela Bowman, Åsta Sulen, et al. · The Lancet Diabetes & Endocrinology · 180
PDF
Efficacy and Safety of Weekly Somatrogon vs Daily Somatropin in Children With Growth Hormone Deficiency: A Phase 3 Study
2022 · Cheri L Deal, Joel Steelman, et al. · The Journal of Clinical Endocrinology & Metabolism · 124
PDF
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
2023 · Lori M Laffel, Thomas Danne, et al. · The Lancet Diabetes & Endocrinology · 121
PDF
Clinical guidelines «Obesity in children»
2021 · V. A. Peterkova, O. B. Bezlepkina, et al. · Problems of Endocrinology · 111
PDF
Long-Acting C-Terminal Peptide–Modified hGH (MOD-4023): Results of a Safety and Dose-Finding Study in GHD Children
2017 · Nataliya Zelinska, Violeta Iotova, et al. · The Journal of Clinical Endocrinology & Metabolism · 81
A Randomized Phase 2 Study of Long-Acting TransCon GH vs Daily GH in Childhood GH Deficiency
2017 · Pierre Chatelain, Oleg Malievskiy, et al. · The Journal of Clinical Endocrinology & Metabolism · 64
PDF
High frequency of mutations in 'dyshormonogenesis genes' in severe congenital hypothyroidism
2018 · Nina Makretskaya, Olga Bezlepkina, et al. · PLoS ONE · 59
PDF
An open-label extension of a phase 2 dose-finding study of once-weekly somatrogon vs. once-daily Genotropin in children with short stature due to growth hormone deficiency: results following 5 years of treatment
2023 · Zvi Zadik, Nataliya Zelinska, et al. · Journal of Pediatric Endocrinology and Metabolism · 45
PDF
Safety and Efficacy of Lonapegsomatropin in Children With Growth Hormone Deficiency: enliGHten Trial 2-Year Results
2022 · Aristides K Maniatis, Samuel J Casella, et al. · The Journal of Clinical Endocrinology & Metabolism · 35
Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
2020 · Thomas Danne, William V. Tamborlane, et al. · Diabetes Care · 28
Diabetes mellitus type 1 in childhood
2020 · Valentina A. Peterkova, Marina V. Shestakova, et al. · Diabetes Mellitus · 24
PDF
Clinical guidelines «Obesity in children»
2024 · O. V. Vasyukova, P. L. Okorokov, et al. · Obesity and metabolism · 20
PDF
Clinical guidelines «Precocious puberty»
2021 · V. A. Peterkova, I. L. Alimova, et al. · Problems of Endocrinology · 19
PDF
Children with Growth Hormone Deficiency Treated with Lonapegsomatropin Demonstrated Sustained Height Improvements for up to 6 Years: enliGHten Trial Final Results
2025 · Aristides K. Maniatis, Paul S. Thornton, et al. · Hormone Research in Paediatrics · 14
Evaluation of FreeStyle Libre in pediatric t1dm: improved glycemic control, reduction in diabetic ketoacidosis and severe hypoglycemia
2022 · D. N. Laptev, O. B. Bezlepkina, et al. · Problems of Endocrinology · 14
PDF
Clinical guidelines «Thyroiditis in children»
2021 · V. A. Peterkova, O. B. Bezlepkina, et al. · Clinical and experimental thyroidology · 10
PDF
Russian national consensus. Diagnostics and treatment of hypopituitarism in children and adolescences
2019 · Elena V. Nagaeva, Tatiana Y. Shiryaeva, et al. · Problems of Endocrinology · 9
Switch Data From the Open-Label Extension of the Pivotal Phase 3 Study of Once Weekly Somatrogon Compared to Daily Somatropin in Pediatric Patients With Growth Hormone Deficiency (pGHD)
2021 · Michael Wajnrajch, Bradley Scott Miller, et al. · Journal of the Endocrine Society · 5
PDF
The quality of medical aid provided to the children with type 1 diabetes mellitus
2015 · I I Dedov, V A Peterkova, et al. · Problems of Endocrinology · 5
PDF
Results From an Open-Label Extension of the Phase 2 Dose Finding Study of Once Weekly Somatrogon vs Daily Genotropin in Pediatric Patients With Growth Hormone Deficiency (GHD)
2021 · Zvi Zadik, Nataliya Zelinska, et al. · Journal of the Endocrine Society · 4
Study of molecular basis of thyroid dysgenesis
2018 · Nina A. Makretskaya, Olga B. Bezlepkina, et al. · Clinical and experimental thyroidology · 4
PDF
Top Line Results of Once-Weekly, CTP-Modified Human GH (MOD-4023): Phase 2 Dose Finding Study in Children with GH Deficiency
2014 · Zvi Zadik, Ron G. Rosenfeld, et al. · 53rd ESPE Meeting · 4
OR21-04 Long-term Efficacy And Safety Of Once-weekly Somatrogon In Pediatric Subjects With Growth Hormone Deficiency: Results From Up To 8 Years Of Somatrogon Treatment
2023 · Zvi Zadik, Nataliya Zelinska, et al. · Journal of the Endocrine Society · 3
Clinical, hormonal and molecular-genetic characteristics of monogenic diabetes mellitus associated with the mutations in the INS gene
2022 · Yu. V. Tikhonovich, E. E. Petryaykina, et al. · Diabetes Mellitus · 3
PDF
SAT-LB15 24-Month Efficacy and Safety of Once Weekly and Every Other Week Administration of GX-H9, Hybrid FC-Fused Long-Acting Human Growth Hormone: A Phase 2 Study in Children With Growth Hormone Deficiency
2020 · Oleg Malievskiy, Aryaev Mykola, et al. · Journal of the Endocrine Society · 3
PDF
Works count: 69
Citation count: 1,005
H-index: 14
I10-index: 16
Year
Topic
Type